Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead? [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
It consists of the company's weight loss drugs: Mounjaro, approved for type 2 diabetes but also prescribed off-label for weight control, and Zepbound, specifically approved for the weight control indication. These drugs, both dual GIP/GLP-1 receptor agonists, work by acting on hormones involved in the digestion process -- and as a result they help control blood sugar levels and appetite. Lilly and its big pharma rival Novo Nordisk today dominate the weight loss drug market, but competition may be on the horizon. Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day. Sign Up For Free » In fact, one up-and-coming player is attracting a lot of attention these days, thanks to its fantastic clinical trial results. And its first weight loss candidate may soon launch phase 3 trials, the last stage of development prior to regulatory review. I'm talking about Viking Therapeutics (NASDAQ: VKTX) Should you forget Eli Lilly and buy this magnificent biotec
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Yahoo Finance [Yahoo! Finance]Yahoo! Finance
- Pound slumps to lowest level in four months [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk A/S (NVO) Trembled At The End Of The Quarter [Yahoo! Finance]Yahoo! Finance
- Dr. Sanjay Gupta: Blockbuster weight loss drugs are revealing what we still don't understand about obesity [CNN]CNN
- Dr. Sanjay Gupta: Blockbuster weight loss drugs are revealing what we still don't understand about obesity [CNN]CNN
NVO
Earnings
- 11/7/24 - Beat
NVO
Sec Filings
- 11/14/24 - Form 6-K
- 11/13/24 - Form 6-K
- 11/8/24 - Form 6-K
- NVO's page on the SEC website